<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.0.2" -->
<rss version="0.92">
<channel>
	<title>Recent Developments in Immunology</title>
	<link>http://kendallasmith.com/contact</link>
	<description>Kendall A. Smith, M.D.</description>
	<lastBuildDate>Fri, 03 Nov 2006 21:35:54 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Entry for November 1, 2006</title>
		<description>As concerns FOXP3 expression by T-Regs, originally Sakaguchi's group reported that activation of peripheral murine T cells via TCR/CD28 did not result in de novo expression of FOXP3 by FOXP3-negative cells, nor did it enhance or suppress the expression of FOXP3-positive cells (Science 299:1057, 2003).  Subsequently, Morgan and co-workers reported ...</description>
		<link>http://kendallasmith.com/contact/2006/11/01/entry-for-november-1-2006/</link>
			</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.331 seconds -->
